Skip to content

Comparison of Two Programs for Weight Loss and Impact on Metabolic Syndrome

Comparison of Two Programs for Weight Loss and Impact on Metabolic Syndrome

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02023515
Enrollment
49
Registered
2013-12-30
Start date
2013-12-31
Completion date
2014-07-31
Last updated
2017-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metabolic Syndrome

Keywords

weight loss, metabolic syndrome, stress, obesity

Brief summary

The purpose of this study is to learn the impact stress may have on weight management and emotional eating.

Detailed description

The investigator's long-term goal is to contribute to the development of empirically-based, clinically-useful weight loss and weight maintenance interventions. The objective in this application is to obtain proof of feasibility for a weight loss and maintenance intervention that addresses the underlying issue of stress, as an effective approach to long-term weight loss and maintenance. The central hypothesis for this application is that the weight management intervention utilizing stress management skills will produce weight loss and significant improvements in stress and metabolic syndrome biomarkers at 10 and 20 weeks follow-up. This hypothesis was formulated based upon data showing that stress is associated with increased risk of obesity and a few small studies that have shown this method of stress management can produce long-term weight loss and maintenance and decreased depression and stress. The rationale for the proposed studies is that proof of feasibility for such an intervention will enable subsequent definitive studies at the R01 level. If, however, the investigators were to unexpectedly disprove the concept, such a result would also be valuable because it would lead the investigators to shift focus and redistribute resources accordingly. To test the central hypothesis, and thereby accomplish the objective for this application, the following specific aims will be pursued: 1. Compare a stress management based program to a standard behavioral weight loss program for weight loss and cost-effectiveness. The approach will involve two different intervention groups. Group 1(control) will receive a standard behavioral weight loss program. Group 2 will receive a stress management based intervention built on research in neuroscience and principles of the attachment theory. 2. Determine secondary outcomes from both interventions, including stress as measured by the perceived stress scale. It is hypothesized that Group 2 will show greater improvements in stress at both 10 and 20 weeks follow-up than Group 1. At the completion of this study, the investigators expect to determine the type of intervention that produces the greatest weight loss in a community sample at 10 and 20 weeks follow-up. The investigators will also have determined what impact the two interventions have on secondary outcomes, including stress as measured by salivary cortisol and telomere length; depression, disordered eating patterns, dietary intake, and physical activity.

Interventions

Stress management based program

Standard behavioral weight loss

Sponsors

National Heart, Lung, and Blood Institute (NHLBI)
CollaboratorNIH
Kelly Webber
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
25 Years to 55 Years
Healthy volunteers
No

Inclusion criteria

* be 25-55 years of age * have a BMI of \> 28 and \<45 * meet criteria for at least one additional risk factor for metabolic syndrome (Participants will be screened for waist circumference and blood pressure to ensure inclusion in the study.) * own and use a smart phone.

Exclusion criteria

* have a medical diagnosis of orthopedic or joint problems that may prohibit regular exercise * endorse any of the first three items on the Physical Activity Readiness Questionnaire (PAR-Q): heart problems, chest pain, faintness or dizzy spells * endorse any of the other items on the PAR-Q without a physician's consent * have had a hospitalization for a psychiatric disorder within the last year * have a history of anorexia or bulimia nervosa * have a medical diagnosis of cancer or HIV * have a diagnosis of a major psychiatric disorder (i.e. bipolar disorder or schizophrenia) or taking anti-psychotic medications * be pregnant, nursing, or planning to become pregnant within the study period * be less than 9 months post-partum * have a weight loss of \> 10 pounds in the last six months * be on more than two medications for hypertension control * greater than stage 3 kidney disease * be taking insulin to control diabetes * be taking Coumadin * be taking Lasix * anyone, who in the opinion of the study investigators, would not be a good candidate for the study

Design outcomes

Primary

MeasureTime frameDescription
Weight LossWeight change from baseline to 20 weeksWeight change from baseline to 20 weeks

Secondary

MeasureTime frameDescription
Decrease in StressPSS change from baseline to 20 weeksStress was measured by the Perceived Stress Scale (PSS). This scale measures stress on a scale of 0 to 40 points. The results are reported as a total score on the scale. Higher numbers indicate more stress than lower numbers.

Countries

United States

Participant flow

Participants by arm

ArmCount
Stress Management
Approximately half of the participants will be randomized to a stress management arm. Participants will undergo Emotional Brain Training during a 90 minute session once per week for ten weeks in order to rewire the brain and improve stress management techniques. Emotional brain training: Stress management based program
24
Standard Behavioral Weight Loss
Half of participants will receive a standard behavioral weight loss program in 90 minute sessions once per week for 10 weeks Behavioral weight loss: Standard behavioral weight loss
25
Total49

Baseline characteristics

CharacteristicTotalStress ManagementStandard Behavioral Weight Loss
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
49 Participants24 Participants25 Participants
Age, Continuous45.0 years
STANDARD_DEVIATION 7.9
45.5 years
STANDARD_DEVIATION 8
44.0 years
STANDARD_DEVIATION 8.8
Region of Enrollment
United States
49 participants24 participants25 participants
Sex: Female, Male
Female
41 Participants20 Participants21 Participants
Sex: Female, Male
Male
8 Participants4 Participants4 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 240 / 25
serious
Total, serious adverse events
0 / 240 / 25

Outcome results

Primary

Weight Loss

Weight change from baseline to 20 weeks

Time frame: Weight change from baseline to 20 weeks

ArmMeasureValue (MEAN)Dispersion
Stress ManagementWeight Loss1.6 kgStandard Deviation 3.8
Standard Behavioral Weight LossWeight Loss3.9 kgStandard Deviation 3.3
Secondary

Decrease in Stress

Stress was measured by the Perceived Stress Scale (PSS). This scale measures stress on a scale of 0 to 40 points. The results are reported as a total score on the scale. Higher numbers indicate more stress than lower numbers.

Time frame: PSS change from baseline to 20 weeks

ArmMeasureValue (MEAN)
Stress ManagementDecrease in Stress-4.5 units on a scale
Standard Behavioral Weight LossDecrease in Stress-1.8 units on a scale

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026